National Institute of Neurological Disorders and Stroke Epilepsy Common Data Element Updates: Seizure Severity Instruments, Diagnostic Tools, and MRI Recommendations.

Go back to Resources

National Institute of Neurological Disorders and Stroke Epilepsy Common Data Element Updates: Seizure Severity Instruments, Diagnostic Tools, and MRI Recommendations.

Authors:

URL:

Keywords:

Abstract:

Go back to Resources

National Institute of Neurological Disorders and Stroke Common Data Elements: Public Review and Updates to the Stroke Recommendations.

Go back to Resources

National Institute of Neurological Disorders and Stroke Common Data Elements: Public Review and Updates to the Stroke Recommendations.

Authors:

URL:

Keywords:

Abstract:

Go back to Resources

Dismantling the Fragility Index: A demonstration of statistical reasoning.

Go back to Resources

Dismantling the Fragility Index: A demonstration of statistical reasoning.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

URL:

DOI:

Keywords:

Abstract:

Go back to Resources

Updates to the National Institute of Neurological Disorders and Stroke (NINDS) Cerebral Palsy Common Data Elements: Participant Condition Characteristics.

Go back to Resources

Updates to the National Institute of Neurological Disorders and Stroke (NINDS) Cerebral Palsy Common Data Elements: Participant Condition Characteristics.

Authors:

Secondary:

Location:

URL:

Abstract:

Go back to Resources

Intracerebral metastases in solid-tumor patients: natural history and results of treatment.

Go back to Resources

Intracerebral metastases in solid-tumor patients: natural history and results of treatment.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

DOI:

Keywords:

Abstract:

Go back to Resources

Evaluation of the safety and immunogenicity of a booster (third) dose of inactivated subvirion H5N1 influenza vaccine in humans.

Go back to Resources

Evaluation of the safety and immunogenicity of a booster (third) dose of inactivated subvirion H5N1 influenza vaccine in humans.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

DOI:

Keywords:

Abstract:

Go back to Resources

Clinical trials referral resource. Current phase III breast cancer clinical trials.

Go back to Resources

Clinical trials referral resource. Current phase III breast cancer clinical trials.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

Keywords:

Go back to Resources

Clinical trials referral resource. Current clinical trials of R115777 (Zarnestra).

Go back to Resources

Clinical trials referral resource. Current clinical trials of R115777 (Zarnestra).

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

Keywords:

Go back to Resources

Clinical trials referral resource. Current clinical trials of bortezomib.

Go back to Resources

Clinical trials referral resource. Current clinical trials of bortezomib.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

Keywords:

Go back to Resources

Clinical trials referral resource. Current clinical trials for the proteasome inhibitor PS-341.

Go back to Resources

Clinical trials referral resource. Current clinical trials for the proteasome inhibitor PS-341.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

Keywords:

Go back to Resources

Subscribe to